{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:35:47Z","timestamp":1793025347575,"version":"4.5.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Healthcare of Republic of Kazakhstan","award":["N 0104 RK 00133"],"award-info":[{"award-number":["N 0104 RK 00133"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s40620-018-0548-5","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T04:26:14Z","timestamp":1541564774000},"page":"65-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Infusion of autologous bone marrow derived mononuclear stem cells potentially reduces urinary markers in diabetic nephropathy"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9844-8772","authenticated-orcid":false,"given":"Abduzhappar","family":"Gaipov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhannat","family":"Taubaldiyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manarbek","family":"Askarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiyrkhan","family":"Turebekov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Kozina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Askhat","family":"Myngbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ulyanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saltanat","family":"Tuganbekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,7]]},"reference":[{"issue":"9911","key":"548_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2014","unstructured":"Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet 383(9911):69\u201382. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(13)60591-7","journal-title":"Lancet"},{"key":"548_CR2","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","volume":"3","author":"A Katsarou","year":"2017","unstructured":"Katsarou A, Gudbjornsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA, Lernmark A (2017) Type 1 diabetes mellitus. Nat Rev Dis Primers 3:17016. \n                    https:\/\/doi.org\/10.1038\/nrdp.2017.16","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"548_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s00125-015-3785-3","volume":"59","author":"S Hadjadj","year":"2016","unstructured":"Hadjadj S, Cariou B, Fumeron F, Gand E, Charpentier G, Roussel R, Kasmi AA, Gautier JF, Mohammedi K, Gourdy P, Saulnier PJ, Feigerlova E, Marre M, French JDNCRI, Group Ss, Group Ds (2016) Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes. Diabetologia 59(1):208\u2013216. \n                    https:\/\/doi.org\/10.1007\/s00125-015-3785-3","journal-title":"Diabetologia"},{"issue":"3","key":"548_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/MNH.0b013e3283293db1","volume":"18","author":"BA Perkins","year":"2009","unstructured":"Perkins BA, Krolewski AS (2009) Early nephropathy in type 1 diabetes: the importance of early renal function decline. Curr Opin Nephrol Hypertens 18(3):233\u2013240. \n                    https:\/\/doi.org\/10.1097\/MNH.0b013e3283293db1","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"548_CR5","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2337\/dc10-0199","volume":"33","author":"S-i Araki","year":"2010","unstructured":"Araki S-i, Haneda M, Koya D, Isshiki K, Kume S, Sugimoto T, Kawai H, Nishio Y, Kashiwagi A, Uzu T (2010) Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria. Diabetes care 33(8):1805\u20131810","journal-title":"Diabetes care"},{"issue":"5","key":"548_CR6","first-page":"357","volume":"55","author":"H Okonogi","year":"2001","unstructured":"Okonogi H, Nishimura M, Utsunomiya Y, Hamaguchi K, Tsuchida H, Miura Y, Suzuki S, Kawamura T, Hosoya T, Yamada K (2001) Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin Nephrol 55(5):357\u2013364","journal-title":"Clin Nephrol"},{"issue":"2","key":"548_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1681\/ASN.2006080882","volume":"18","author":"KM Schmidt-Ott","year":"2007","unstructured":"Schmidt-Ott KM, Mori K, Li JY, Kalandadze A, Cohen DJ, Devarajan P, Barasch J (2007) Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 18(2):407\u2013413. \n                    https:\/\/doi.org\/10.1681\/ASN.2006080882","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"548_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12020-009-9187-x","volume":"36","author":"YH Yang","year":"2009","unstructured":"Yang YH, He XJ, Chen SR, Wang L, Li EM, Xu LY (2009) Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study. Endocrine 36(1):45\u201351. \n                    https:\/\/doi.org\/10.1007\/s12020-009-9187-x","journal-title":"Endocrine"},{"issue":"10","key":"548_CR9","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/j.1464-5491.2010.03083.x","volume":"27","author":"SE Nielsen","year":"2010","unstructured":"Nielsen SE, Schjoedt KJ, Astrup AS, Tarnow L, Lajer M, Hansen PR, Parving HH, Rossing P (2010) Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet Med 27(10):1144\u20131150. \n                    https:\/\/doi.org\/10.1111\/j.1464-5491.2010.03083.x","journal-title":"Diabet Med"},{"issue":"6","key":"548_CR10","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3109\/0886022X.2015.1040699","volume":"37","author":"M Taghizadeh-Ghehi","year":"2015","unstructured":"Taghizadeh-Ghehi M, Sarayani A, Ashouri A, Ataei S, Moslehi A, Hadjibabaie M (2015) Urine neutrophil gelatinase associated lipocalin as an early marker of acute kidney injury in hematopoietic stem cell transplantation patients. Renal failure 37(6):994\u2013998","journal-title":"Renal failure"},{"issue":"10","key":"548_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/jvh.12916","volume":"25","author":"I Carey","year":"2018","unstructured":"Carey I, Byrne R, Childs K, Horner M, Bruce M, Wang B, Dusheiko G, Agarwal K (2018) Serum NGAL can act as an early renal safety biomarker during long-term nucleos(t)ide analogue antiviral therapy in chronic hepatitis B. J Viral Hepat 25(10):1139\u20131150. \n                    https:\/\/doi.org\/10.1111\/jvh.12916","journal-title":"J Viral Hepat"},{"issue":"2","key":"548_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2215\/CJN.03530708","volume":"4","author":"D Bolignano","year":"2009","unstructured":"Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M (2009) Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 4(2):337\u2013344. \n                    https:\/\/doi.org\/10.2215\/CJN.03530708","journal-title":"Clin J Am Soc Nephrol"},{"issue":"14","key":"548_CR13","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1001\/jama.294.14.1782","volume":"294","author":"P Finne","year":"2005","unstructured":"Finne P, Reunanen A, Stenman S, Groop PH, Gronhagen-Riska C (2005) Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 294(14):1782\u20131787. \n                    https:\/\/doi.org\/10.1001\/jama.294.14.1782","journal-title":"JAMA"},{"issue":"11","key":"548_CR14","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.5966\/sctm.2015-0272","volume":"5","author":"LC Davies","year":"2016","unstructured":"Davies LC, Alm JJ, Heldring N, Moll G, Gavin C, Batsis I, Qian H, Sigvardsson M, Nilsson B, Kyllonen LE, Salmela KT, Carlsson PO, Korsgren O, Le Blanc K (2016) Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro. Stem Cells Transl Med 5(11):1485\u20131495. \n                    https:\/\/doi.org\/10.5966\/sctm.2015-0272","journal-title":"Stem Cells Transl Med"},{"issue":"15","key":"548_CR15","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jama.2009.470","volume":"301","author":"CE Couri","year":"2009","unstructured":"Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simoes BP, Martinez EZ, Foss MC, Burt RK, Voltarelli JC (2009) C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 301(15):1573\u20131579. \n                    https:\/\/doi.org\/10.1001\/jama.2009.470","journal-title":"JAMA"},{"issue":"2","key":"548_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2337\/db14-0656","volume":"64","author":"PO Carlsson","year":"2015","unstructured":"Carlsson PO, Schwarcz E, Korsgren O, Le Blanc K (2015) Preserved beta-cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes 64(2):587\u2013592. \n                    https:\/\/doi.org\/10.2337\/db14-0656","journal-title":"Diabetes"},{"issue":"14","key":"548_CR17","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1001\/jama.297.14.1568","volume":"297","author":"JC Voltarelli","year":"2007","unstructured":"Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KC, Foss-Freitas MC, Simoes BP, Foss MC, Squiers E, Burt RK (2007) Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297(14):1568\u20131576. \n                    https:\/\/doi.org\/10.1001\/jama.297.14.1568","journal-title":"JAMA"},{"issue":"11","key":"548_CR18","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.bbmt.2009.07.022","volume":"15","author":"F Ezquer","year":"2009","unstructured":"Ezquer F, Ezquer M, Simon V, Pardo F, Yanez A, Carpio D, Conget P (2009) Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice. Biol Blood Marrow Transpl 15(11):1354\u20131365. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2009.07.022","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"548_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.diabres.2012.09.034","volume":"98","author":"JH Park","year":"2012","unstructured":"Park JH, Hwang I, Hwang SH, Han H, Ha H (2012) Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action. Diabetes Res Clin Pract 98(3):465\u2013473. \n                    https:\/\/doi.org\/10.1016\/j.diabres.2012.09.034","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"548_CR20","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.bbmt.2013.01.001","volume":"19","author":"S Wang","year":"2013","unstructured":"Wang S, Li Y, Zhao J, Zhang J, Huang Y (2013) Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model. Biol Blood Marrow Transpl 19(4):538\u2013546. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2013.01.001","journal-title":"Biol Blood Marrow Transpl"},{"key":"548_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fendo.2017.00331","volume":"8","author":"JG Penaforte-Saboia","year":"2017","unstructured":"Penaforte-Saboia JG, Montenegro RM Jr, Couri CE, Batista LA, Montenegro A, Fernandes VO, Akhtar H, Negrato CA, Malmegrim KCR, Moraes DA, Dias JBE, Simoes BP, Gomes MB, Oliveira MC (2017) Microvascular complications in type 1 diabetes: a comparative analysis of patients treated with autologous nonmyeloablative hematopoietic stem-cell transplantation and conventional medical therapy. Front Endocrinol (Lausanne) 8:331. \n                    https:\/\/doi.org\/10.3389\/fendo.2017.00331","journal-title":"Front Endocrinol (Lausanne)"},{"key":"548_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ebiom.2016.09.011","volume":"12","author":"DK Packham","year":"2016","unstructured":"Packham DK, Fraser IR, Kerr PG, Segal KR (2016) Allogeneic mesenchymal precursor cells (MPC) in diabetic nephropathy: a randomized, placebo-controlled, dose escalation study. EBioMedicine 12:263\u2013269. \n                    https:\/\/doi.org\/10.1016\/j.ebiom.2016.09.011","journal-title":"EBioMedicine"},{"issue":"9","key":"548_CR23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ckd EPI (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"548_CR24","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.2337\/dc13-S067","volume":"36","author":"A American Diabetes","year":"2013","unstructured":"American Diabetes A (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care 36(Suppl 1):S67\u2013S74. \n                    https:\/\/doi.org\/10.2337\/dc13-S067","journal-title":"Diabetes Care"},{"issue":"2 Suppl 2","key":"548_CR25","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1053\/j.ajkd.2006.12.005","volume":"49","author":"K","year":"2007","unstructured":"KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease (2007) Am J Kidney Dis 49(2 Suppl 2):S12\u2013S154. \n                    https:\/\/doi.org\/10.1053\/j.ajkd.2006.12.005","journal-title":"Am J Kidney Dis"},{"issue":"37","key":"548_CR26","first-page":"14","volume":"3","author":"A Dzholdasbekova","year":"2015","unstructured":"Dzholdasbekova A, Fedotovskikh G, Askarov M, Komsabakova B, Baigenzhina A, Kairatova A, Abylkassymova G (2015) Systemic administration of autologous mononuclear precultured bone marrow stem cells in heart failure. J Clin Med Kaz 3(37):14\u201318","journal-title":"J Clin Med Kaz"},{"issue":"29","key":"548_CR27","first-page":"7","volume":"3","author":"GA Rakhimbekova","year":"2013","unstructured":"Rakhimbekova GA, Tuganbekova SK, Askarov MB, Zhusupova AS, Krivoruchko NA, Akshalova GA, Rahimberlina HA, Gaipov AE, Ponomarenko YN, Temirgalieva AM, Tokbergenova AB (2013) Autologous hematopoietic stem cell transplantation in systemic sclerosis. J Clin Med Kaz 3(29):7\u201310","journal-title":"J Clin Med Kaz"},{"issue":"1","key":"548_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/0886022X.2016.1244080","volume":"39","author":"AH Hamza","year":"2017","unstructured":"Hamza AH, Al-Bishri WM, Damiati LA, Ahmed HH (2017) Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy. Ren Fail 39(1):67\u201376. \n                    https:\/\/doi.org\/10.1080\/0886022X.2016.1244080","journal-title":"Ren Fail"},{"issue":"6","key":"548_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbmt.2008.01.006","volume":"14","author":"FE Ezquer","year":"2008","unstructured":"Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yanez AJ, Conget PA (2008) Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transpl 14(6):631\u2013640. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2008.01.006","journal-title":"Biol Blood Marrow Transpl"},{"key":"548_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13098-017-0248-7","volume":"9","author":"S Bhansali","year":"2017","unstructured":"Bhansali S, Dutta P, Yadav MK, Jain A, Mudaliar S, Hawkins M, Kurpad AV, Pahwa D, Yadav AK, Sharma RR, Jha V, Marwaha N, Bhansali S, Bhansali A (2017) Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on beta-cell function and insulin sensitivity. Diabetol Metab Syndr 9:50. \n                    https:\/\/doi.org\/10.1186\/s13098-017-0248-7","journal-title":"Diabetol Metab Syndr"},{"issue":"227","key":"548_CR31","first-page":"2","volume":"4","author":"M Ezquer","year":"2014","unstructured":"Ezquer M, Arango-Rodriguez M, Giraud-Billoud M, Ezquer F (2014) Mesenchymal stem cell therapy in type 1 diabetes mellitus and its main complications: from experimental findings to clinical practice. J Stem Cell Res Ther 4(227):2","journal-title":"J Stem Cell Res Ther"},{"issue":"3","key":"548_CR32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.mehy.2008.03.046","volume":"71","author":"Y-X Xu","year":"2008","unstructured":"Xu Y-X, Chen L, Wang R, Hou W-K, Lin P, Sun L, Sun Y, Dong Q-Y (2008) Mesenchymal stem cell therapy for diabetes through paracrine mechanisms. Med Hypotheses 71(3):390\u2013393","journal-title":"Med Hypotheses"},{"issue":"2","key":"548_CR33","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1172\/JCI27699","volume":"116","author":"G Remuzzi","year":"2006","unstructured":"Remuzzi G, Benigni A, Remuzzi A (2006) Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116(2):288\u2013296. \n                    https:\/\/doi.org\/10.1172\/JCI27699","journal-title":"J Clin Invest"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-018-0548-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:15Z","timestamp":1777564575000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/32\/1\/65\/8328195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["548"],"URL":"https:\/\/doi.org\/10.1007\/s40620-018-0548-5","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,7]]},"assertion":[{"value":"28 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The protocol of this study (protocol No 004\/\u0421\u0422-14; 24th April 2014) was approved by the Ethical Committee of the National Scientific Medical Research Centre.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients. Research involving human participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}